Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Achaogen Inc AKAOQ

Healthcare Biotechnology
"Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is... see more

Recent & Breaking News (OTCPK:AKAOQ)

Achaogen Shares Upgraded To Outperform By Wedbush Following Optimistic Survey

Benzinga.com  June 14, 2016

12 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  June 14, 2016

Achaogen Announces Plazomicin Data Presentations at ASM Microbe 2016 Annual Meeting

GlobeNewswire June 9, 2016

Achaogen Adds Tobin Schilke as Chief Financial Officer

GlobeNewswire June 3, 2016

Mid-Afternoon Market Update: U.S. Stocks Turn Positive; American Woodmark Shares Fall On Earnings Miss

Benzinga.com  June 2, 2016

Mid-Morning Market Update: Markets Open Lower; Joy Global Profit Tops Expectations

Benzinga.com  June 2, 2016

11 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  June 2, 2016

Achaogen Raises $25 Million in Private Placement

GlobeNewswire June 2, 2016

Achaogen Awarded $20 Million Contract Option by BARDA to Support Development of Plazomicin for Multi-Drug Resistant Gram-Negative Infections

GlobeNewswire June 2, 2016

Achaogen Reaches 50 Percent Patient Enrollment in Phase 3 EPIC Registration Trial of Plazomicin

GlobeNewswire June 2, 2016

Achaogen and Crystal Bioscience Enter into Collaboration and License Agreement to Identify and Develop Antibodies for Multiple Targets

GlobeNewswire May 10, 2016

Achaogen Reports First Quarter 2016 Financial Results

GlobeNewswire May 5, 2016

Achaogen Announces New Employment Inducement Grants

GlobeNewswire April 22, 2016

Achaogen Awarded $2.4 Million Contract Option by NIAID to Support Development of LpxC Inhibitors for the Treatment of Serious Bacterial Infections

GlobeNewswire April 21, 2016

Achaogen to Present at the 15th Annual Needham Health Care Conference

GlobeNewswire April 6, 2016

Achaogen Announces Acceleration of Expected Timeline for Reporting Top-Line Results from Phase 3 EPIC Registration Clinical Trial of Plazomicin

GlobeNewswire April 5, 2016

Achaogen Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update

GlobeNewswire March 15, 2016

Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2015 Financial Results on March 15, 2016

GlobeNewswire March 8, 2016

Achaogen and TRIANNI Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform

GlobeNewswire February 8, 2016

Achaogen Joins Leading International Healthcare Companies in Declaration to Further Mobilize Governments to Combat the Threat of Antimicrobial Resistance

GlobeNewswire January 21, 2016